Prednicarbate

{{Short description|Chemical compound}}

{{Drugbox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 396722627

| IUPAC_name = 17-[(Ethoxycarbonyl)oxy]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-yl propionate

| image = Prednicarbate.png

| width = 250px

| tradename =

| Drugs.com = {{drugs.com|monograph|prednicarbate}}

| MedlinePlus = a604021

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration = Topical

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| IUPHAR_ligand = 7605

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 73771-04-7

| ATC_prefix = D07

| ATC_suffix = AC18

| ATC_supplemental =

| PubChem = 6714002

| DrugBank_Ref = {{drugbankcite|changed|drugbank}}

| DrugBank = DB01130

| UNII_Ref = {{fdacite|changed|FDA}}

| UNII = V901LV1K7D

| ChEMBL_Ref = {{ebicite|changed|EBI}}

| ChEMBL = 1200386

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = 5145991

| smiles = O=C(OCC(=O)[C@@]1(OC(=O)OCC)CC[C@H]2[C@H]4[C@H]([C@@H](O)C[C@]12C)[C@]/3(/C=C\C(=O)\C=C\3CC4)C)CC

| StdInChI_Ref = {{stdinchicite|changed|chemspider}}

| StdInChI = 1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}

| StdInChIKey = FNPXMHRZILFCKX-KAJVQRHHSA-N

| C=27 | H=36 | O=8

| synonyms = {2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl} propanoate

}}

Prednicarbate is a relatively new topical corticosteroid drug. It is similar in potency to hydrocortisone. Corticosteroids have always been an important part of the pharmacological arsenal of dermatology; however, their tendency to produce side-effects has caused the need to search for new preparations.{{cite book|url=https://books.google.com/books?id=4-MjAQAAMAAJ|title=United States Pharmacopeia, the National Formulary|publisher=United States Pharmacopeial Convention, Incorporated|year=2008|isbn=978-1-889788-53-1|page=3060}}

It is nonhalogenated.{{cite journal |vauthors=Gupta AK, Chow M |title=A review of prednicarbate (Dermatop) |journal=Skin Therapy Lett. |volume=9 |issue=10 |pages=5–6, 9 |year=2004 |pmid=15657633 |url=http://www.skintherapyletter.com/2004/9.10/2.html}}

References